Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Core Insights - Apollo Medical Holdings, Inc. has granted equity awards to its newly-hired Chief Medical Officer, Dr. Dinesh M. Kumar, as part of its Employment Inducement Award Plan, which is designed to attract new talent [1][2] Group 1: Equity Awards - The Compensation Committee granted 85,130 shares of time-based restricted common stock and 65,265 shares of performance-based restricted common stock to Dr. Kumar, effective January 23, 2024 [1] - The time-based restricted stock will vest over three years in equal annual installments, while the performance-based stock will vest semi-annually starting July 1, 2024, contingent on performance goals [2] - An additional grant of time-based restricted common stock valued at $250,000 will be awarded to another newly-hired non-executive employee, effective February 5, 2024, also vesting over three years [3] Group 2: Company Overview - ApolloMed is a physician-centric, technology-powered healthcare company focused on enabling providers to deliver value-based care [4] - The company operates an integrated healthcare delivery platform that supports providers in participating in value-based care arrangements, aiming for cost-effective outcomes-based medical care [4] - ApolloMed's subsidiaries include management services organizations and independent practice associations, and it participates in the Centers for Medicare & Medicaid Services Innovation Center models [4]